Impact of outsourcing strategies
Outsourcing challenges in pharmaceutical supply chains

The outsourcing strategies implemented in the pharmaceutical sector in the 2000s are at the root of current supply chain vulnerabilities. The Covid-19 pandemic only served to highlight these weaknesses, which were already well known to healthcare professionals. Indeed, since 2010, drug shortages have been steadily increasing. These shortages can be explained by a number of factors, not least the forecasting difficulties associated with market uncertainty and the growing unpredictability of epidemics.

Another disruptive factor is the discontinuation of certain products. At a time when Europe occupies a dominant position in the world drug trade, accounting for 75% of global exports, the situation is paradoxical.